Application
Library of pharmacologically active compounds LOPAC®1280 - small scale has been used to screen for the suppressors of niclosamide- and nigericin-induced interleukin (IL-1β) release.
Features and Benefits
Includes the latest, drug-like molecules in the fields of Cell Signaling & Neuroscience: Apoptosis G Proteins & Cyclic Nucleotides Gene Regulation & Expression Ion Channels Lipid Signaling Multi-Drug Resistance Neurotransmission Phosphorylation
SDFile provided to construct a database containing: Structure Primary Name Secondary Name Pharmacological Activity Product Number Rack Position
General description
Compounds are arranged in 96-well format in 16 racks of 80, one compound per well (25 µl at 10 mM in DMSO in archival storage racks).
Legal Information
LOPAC is a registered trademark of Sigma-Aldrich Co. LLC
Other Notes
For sale outside of the U.S. only. U.S. customers should refer to Product Code LO4100.
This product has met the following criteria to qualify for the following awards: